Corestemchemon Inc. is a company located in Seoul, South Korea. It was formed in December 2022 through the merger of Coastem, specializing in stem cell therapies, and ChemOn, a leading domestic non-clinical CRO (Contract Research Organization) in the market. The company aims to enter the global market and provide maximum synergy by leveraging the best technology and human resources from both entities. Corestemchemon Inc. prioritizes customer satisfaction and aims to be a socially necessary company. They also emphasize shareholder-friendly management and aim to fulfill their responsibilities to investors. The company focuses on continuous research and development, value investment, and improving the welfare of all mankind. Their ultimate goal is to become a global pharmaceutical company that contributes to the value of human lives. Corestemchemon Inc. expresses gratitude for the support and encouragement received and seeks continued support for their endeavors.
Headquarters
24, Pangyo-Ro 255Beon-Gil, Bundang-Gu
Seoul; Seoul;
Contact Details: Purchase the Corestemchemon Inc. report to view the information.
Website: http://www.corestem.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service